Breast cancer metastasis to bone: From epithelial to mesenchymal transition to breast osteoblast-like cells.

BOLCs Bone metastasis Breast cancer Epithelial to mesenchymal transition Microcalcifications Molecular imaging

Journal

Seminars in cancer biology
ISSN: 1096-3650
Titre abrégé: Semin Cancer Biol
Pays: England
ID NLM: 9010218

Informations de publication

Date de publication:
07 2021
Historique:
received: 15 11 2019
revised: 13 01 2020
accepted: 13 01 2020
pubmed: 12 2 2020
medline: 4 3 2022
entrez: 12 2 2020
Statut: ppublish

Résumé

In this review we highlighted the newest aspects concerning the physiopathology of breast cancer metastatization into the bone including: a) in situ biomarkers of breast cancer metastatic diseases, b) biological processes related to the origin of metastatic cells (epithelial to mesenchymal transition), c) the nature and the possible role of Breast Osteoblast-Like Cells in the formation of bone lesions and d) the prognostic value of breast microcalcifications for the bone metastatic disease. In addition, the more recent data about the biology of breast cancer metastatic process and the origin and function of Breast Osteoblast-Like Cells have been analyzed to propose the use of molecular imaging investigations able to identify early neoplastic lesions with high propensity to form bone metastasis in vivo.

Identifiants

pubmed: 32045651
pii: S1044-579X(20)30005-5
doi: 10.1016/j.semcancer.2020.01.004
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

155-164

Informations de copyright

Copyright © 2020 Elsevier Ltd. All rights reserved.

Auteurs

Manuel Scimeca (M)

Department of Biomedicine and Prevention, University of Rome "Tor Vergata", Via Montpellier 1, Rome, 00133, Italy; San Raffaele University, Via di Val Cannuta 247, 00166, Rome, Italy; Fondazione Umberto Veronesi (FUV), Piazza Velasca 5, 20122, Milano, Mi, Italy; Saint Camillus International University of Health Sciences, Via di Sant'Alessandro, 8, 00131 Rome, Italy. Electronic address: manuel.scimeca@uniroma2.it.

Donata Trivigno (D)

Department of Experimental Medicine, University "Tor Vergata", Via Montpellier 1, Rome, 00133, Italy.

Rita Bonfiglio (R)

Department of Experimental Medicine, University "Tor Vergata", Via Montpellier 1, Rome, 00133, Italy.

Sara Ciuffa (S)

Department of Clinical Sciences and Translational Medicine, University of Rome "Tor Vergata", 00133, Rome, Italy.

Nicoletta Urbano (N)

Nuclear Medicine, Policlinico "Tor Vergata", Rome, Italy.

Orazio Schillaci (O)

Department of Biomedicine and Prevention, University of Rome "Tor Vergata", Via Montpellier 1, Rome, 00133, Italy; IRCCS Neuromed, Pozzilli, Italy.

Elena Bonanno (E)

Department of Experimental Medicine, University "Tor Vergata", Via Montpellier 1, Rome, 00133, Italy; "Diagnostica Medica" and "Villa dei Platani", Avellino, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH